These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31833496)

  • 1. Exploiting structure-activity relationships of QS-21 in the design and synthesis of streamlined saponin vaccine adjuvants.
    Ghirardello M; Ruiz-de-Angulo A; Sacristan N; Barriales D; Jiménez-Barbero J; Poveda A; Corzana F; Anguita J; Fernández-Tejada A
    Chem Commun (Camb); 2020 Jan; 56(5):719-722. PubMed ID: 31833496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis.
    Fernández-Tejada A; Tan DS; Gin DY
    Acc Chem Res; 2016 Sep; 49(9):1741-56. PubMed ID: 27568877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresol.
    Fernández-Tejada A; Chea EK; George C; Gardner JR; Livingston PO; Ragupathi G; Tan DS; Gin DY
    Bioorg Med Chem; 2014 Nov; 22(21):5917-23. PubMed ID: 25284254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidating the Mechanisms of Action of Saponin-Derived Adjuvants.
    Marciani DJ
    Trends Pharmacol Sci; 2018 Jun; 39(6):573-585. PubMed ID: 29655658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of potent Quillaja saponin vaccine adjuvants.
    Adams MM; Damani P; Perl NR; Won A; Hong F; Livingston PO; Ragupathi G; Gin DY
    J Am Chem Soc; 2010 Feb; 132(6):1939-45. PubMed ID: 20088518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semisynthesis of Analogues of the Saponin Immunoadjuvant QS-21.
    Fernández-Tejada A; Walkowicz WE; Tan DS; Gin DY
    Methods Mol Biol; 2017; 1494():45-71. PubMed ID: 27718185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Effect on Adjuvanticity of Saponins.
    Wang P; Ding X; Kim H; Michalek SM; Zhang P
    J Med Chem; 2020 Mar; 63(6):3290-3297. PubMed ID: 32101001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Evaluation of a QS-17/18-Based Vaccine Adjuvant.
    Wang P; Škalamera Đ; Sui X; Zhang P; Michalek SM
    J Med Chem; 2019 Feb; 62(3):1669-1676. PubMed ID: 30656932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a minimal saponin vaccine adjuvant based on QS-21.
    Fernández-Tejada A; Chea EK; George C; Pillarsetty N; Gardner JR; Livingston PO; Ragupathi G; Lewis JS; Tan DS; Gin DY
    Nat Chem; 2014 Jul; 6(7):635-43. PubMed ID: 24950335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure/function studies on QS-21, a unique immunological adjuvant from Quillaja saponaria.
    Kensil CR; Soltysik S; Wheeler DA; Wu JY
    Adv Exp Med Biol; 1996; 404():165-72. PubMed ID: 8957293
    [No Abstract]   [Full Text] [Related]  

  • 11. Syntheses and mucosal adjuvant activity of simplified oleanolic acid saponins possessing cinnamoyl ester.
    Shirahata T; Nagai T; Hirata N; Yokoyama M; Katsumi T; Konishi N; Nishino T; Makino K; Yamada H; Kaji E; Kiyohara H; Kobayashi Y
    Bioorg Med Chem; 2017 Mar; 25(6):1747-1755. PubMed ID: 28237555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foamy matters: an update on
    Magedans YV; Yendo AC; Costa F; Gosmann G; Fett-Neto AG
    Future Med Chem; 2019 Jun; 11(12):1485-1499. PubMed ID: 31304830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QS-21 Adjuvant: Laboratory-Scale Purification Method and Formulation Into Liposomes.
    Brunner L; Barnier-Quer C; Collin N
    Methods Mol Biol; 2017; 1494():73-86. PubMed ID: 27718186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QS-21 and QS-7: purified saponin adjuvants.
    Kensil CR; Wu JY; Anderson CA; Wheeler DA; Amsden J
    Dev Biol Stand; 1998; 92():41-7. PubMed ID: 9554258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant activities of saponins from the root of Polygala senega L.
    Katselis GS; Estrada A; Gorecki DK; Barl B
    Can J Physiol Pharmacol; 2007 Nov; 85(11):1184-94. PubMed ID: 18066120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QS-21 structure/function studies: effect of acylation on adjuvant activity.
    Liu G; Anderson C; Scaltreto H; Barbon J; Kensil CR
    Vaccine; 2002 Jun; 20(21-22):2808-15. PubMed ID: 12034108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure verification of the vaccine adjuvant QS-7-Api. Synthetic access to homogeneous Quillaja saponaria immunostimulants.
    Deng K; Adams MM; Gin DY
    J Am Chem Soc; 2008 May; 130(18):5860-1. PubMed ID: 18410100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses.
    Newman MJ; Wu JY; Gardner BH; Munroe KJ; Leombruno D; Recchia J; Kensil CR; Coughlin RT
    J Immunol; 1992 Apr; 148(8):2357-62. PubMed ID: 1373166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Oxime-Derivatized Synthetic Triterpene Glycosides as Potent Saponin Vaccine Adjuvants.
    Fuentes R; Aguinagalde L; Pifferi C; Plata A; Sacristán N; Castellana D; Anguita J; Fernández-Tejada A
    Front Immunol; 2022; 13():865507. PubMed ID: 35603193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and evaluation of immunological adjuvant activities of saponins from the roots of Pulsatilla chinensis with less adverse reactions.
    Sun Y; Liu J; Yu H; Gong C
    Int Immunopharmacol; 2010 May; 10(5):584-90. PubMed ID: 20159051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.